Edesa Biotech, Inc. (EDSA)

Edesa Biotech Income Statement

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021	2020	2018
Revenue	0	0	0	0.33	0
Cost of Revenue	0	0	0	0.02	0
Gross Profit	0	0	0	0.31	0
Selling, General & Admin	4.43	5.04	5.73	3.38	0.54
Research & Development	4.79	13.34	17.95	3.33	1.08
Operating Expenses	9.22	18.37	23.68	6.71	1.62
Operating Income	-9.22	-18.37	-23.68	-6.4	-1.62
Other Expense / Income	-0.85	-0.82	-10.34	-0.04	0.25
Pretax Income	-8.37	-17.55	-13.34	-6.36	-1.87
Income Tax	0	0	0	0	0
Net Income	-8.37	-17.55	-13.34	-6.36	-1.87
Shares Outstanding (Basic)	3	2	2	1	0
Shares Outstanding (Diluted)	3	2	2	1	0
Shares Change	36.37%	21.50%	40.32%	165.66%	1229.24%
EPS (Basic)	-2.93	-8.37	-7.70	-5.18	-3.29
EPS (Diluted)	-2.93	-8.37	-7.70	-5.18	-3.29
Free Cash Flow	-6.64	-12.28	-13.67	-4.94	-1.3
Free Cash Flow Per Share	-2.32	-5.86	-7.92	-4.02	-2.80
Gross Margin	-	-	-	94.65%	-
Operating Margin	-	-	-	-1946.72%	-
Profit Margin	-	-	-	-1935.59%	-
Free Cash Flow Margin	-	-	-	-1501.75%	-
EBITDA	-8.19	-17.43	-13.22	-6.31	-1.86
EBITDA Margin	-	-	-	-1917.84%	-
Depreciation & Amortization	0.18	0.12	0.12	0.06	0
EBIT	-8.37	-17.55	-13.34	-6.36	-1.87
EBIT Margin	-	-	-	-1935.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).